Insider Activity of THURMAN RANDY H
According to the SEC Form 4 filings, THURMAN RANDY H, being in a position of
- director at Outlook Therapeutics, Inc.,оver the last 12 months, has bought 5000 shares for $2,145, and sold 0 shares,over all time since 2018-12-21, has bought 55000 shares for $35,047, and sold 0 shares.
Biography of THURMAN RANDY H
No biography is available at this moment.